chrisvoncsefalvay/vaers-outcomes huggingface dataset:
This spontaneous case was reported by a consumer and describes the occurrence of PAIN IN EXTREMITY (arm hurt a little bit), SWELLING (Some swelling), FATIGUE (Fatigue) and DIARRHOEA (Diarrhea) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 017CZIA) for COVID-19 vaccination. No medical history was provided by the reporter. Concomitant products included LISINOPRIL and THYROID (ARMOUR THYROID) for an unknown indication. On 30-Apr-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced PAIN IN EXTREMITY (arm hurt a little bit), SWELLING (Some swelling), FATIGUE (Fatigue) and DIARRHOEA (Diarrhea). At the time of the report, PAIN IN EXTREMITY (arm hurt a little bit), SWELLING (Some swelling), FATIGUE (Fatigue) and DIARRHOEA (Diarrhea) outcome was unknown. The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown. No Treatment information was reported. This case was linked to MOD-2021-207553 (Patient Link). Most recent FOLLOW-UP information incorporated above includes: On 06-Jul-2021: It contains no new information.
Patient states he received the Johnson and Johnson vaccine on Wednesday and noticed swelling in his right arm on Thursday evening. Patient has redness, swelling and tenderness surrounding the administration site.
No additional AEs were reported; The nurse reported that 33 patients received improperly stored vaccines; This spontaneous report was received from a licensed practical nurse and refers to a patient of unknown age and gender. Information regarding the patient's concomitant therapies, concurrent conditions, medical history and historical drugs was not provided.  On 11-MAR-2022, the patient was vaccinated with improperly stored Haemophilus b Conjugate Vaccine (Meningococcal Protein Conjugate) (LIQUID PEDVAXHIB) (dosage regimen was not reported), lot # U026217 and expiration date 02-NOV-2023 administered as prophylaxis.   The improperly stored dose of the suspect vaccine experienced a temperature excursion of 34.3 degree fahrenheit (F) for 55 minutes; no previous temperature excursions were reported.  The call was made due to a digital data logger. No adverse symptoms were reported.; Sender's Comments:  US-009507513-2204USA001821: US-009507513-2204USA001816: US-009507513-2204USA001791:
This spontaneous report was received from a medical assistant refers to multiple unspecified patients of unknown gender and age. Information regarding the patient's medical history, concurrent conditions, drug reactions/allergies and concomitant therapy were not provided. On unknown dates, the patients were vaccinated with improperly stored VAQTA (lot # M015290, expiry date: 20-SEP-2017; lot # K004856, expiry date: 07-DEC-2016; lot # M003025, expiry date: 26-MAY-2017). Medical assistant reported that the vaccine underwent temperature excursion at 63.5 F for 36 hours. The vaccine was exposed to a temperature of 50 F for 12 hours previously as well. No adverse effects were reported. This is one of the several reports received from the same reporter. Additional information has been requested.
Bad chest pains. Center to left side, same side I got my shot. It's deep and my armpit hurts too. I've felt nauseous and hard to breathe. But above all shabby ache in. Does not worsen with breathing
This spontaneous report received from a consumer via social media a company representative concerned a male of unspecified age, race, and ethnicity. The patient's height, and weight were not reported. No past medical history or concurrent conditions were reported. The patient was previously treated with covid-19 vaccine (suspension for injection, route of admin and batch number were not reported) 1 total, dose and start therapy date were not reported for prophylactic vaccination (Dose number in series 1). It was unknown whether patient had any adverse event following vaccination with covid-19 vaccine. The patient received booster of covid-19 vaccine (suspension for injection, route of admin and batch number were not reported) 1 total, dose and start therapy date were not reported for prophylactic vaccination (Dose number in series 2). The batch number was not reported. The company is unable to perform follow up to request batch/lot number. No concomitant medications were reported.  On an unspecified date, the patient experienced blood clots (Dose number in series 1). The reporter stated that her son-in-law had to take both J and J covid jabs and he then developed blood clots. She also stated that he was healthy but forced to take the shot and now he was not the same.  The action taken with covid-19 vaccine was not applicable. The outcome of the blood clots was unknown. This report was serious (Other Medically Important Condition).; Sender's Comments: V0: 20211249099-covid-19 vaccine blood clots. This event(s) is considered unassessable. The event(s) has a compatible/suggestive temporal relationship, is unlabeled, and has unknown scientific plausibility. There is no information on any other factors potentially associated with the event(s).
This report was received from the manufacturer for diphtheria toxoid (+) pertussis acellular 3 component vaccine (+) tetanus toxoid (INFANRIX) and assigned a manufacturer control number. Information was received from a nurse concerning a 5 year old female with no known medical history, no known allergies and no concurrent conditions who on 17Apr03 was vaccinated SC in the right deltoid with a dose of measles virus vaccine live (+) mumps virus vaccine live (+) rubella virus vaccine live (second generation. Concomitant vaccination the same day included a fifth dose of diphtheria toxoid (+) pertussis acellular 3 component vaccine (+) tetanus toxoid (INFANRIX) given IM in the left deltoid and a dose of poliovirus vaccine inactivated (IPOL) given SC in the left deltoid. On 18Apr03, 24 hours after immunization, the pt experienced an injection site reaction in the left deltoid that included pain, swelling and inflammation. Her left arm was stiff and she also experienced irritability and low grade fever. On 20Apr03 the pt recovered. The nurse reported that there was no erythema, tenderness or swelling at the  measles virus vaccine live (+) mumps virus vaccine live (+) rubella virus vaccine live (second generation) site. The nurse considered that the events were related to vaccination with diphtheria toxoid (+) pertussis acellular 3 component vaccine (+) tetanus toxoid (INFANRIX). It was reported that the pt had no adverse experiences following previous vaccinations. The child did not see a physician for treatment. The same reporter indicated 4 other pt's who had similar reactions following vaccination with measles virus vaccine live (+) mumps virus vaccine live (+) rubella virus vaccine live (second generation) and diphtheria toxoid (+) pertussis acellular 3 component vaccine (+) tetanus toxoid (INFANRIX). Additional information has been requested.
Headache, fever, chills, body aches/pain, nausea, diarrhea
Patient given RotaTeq at 8mo15d in clinic, vaccine not to be administered after 8mo. Patient given PO and tolerated as expected with no side effects.
Right after my vaccination my period was 15 days late. It?s usually on the date by one day less or more but never 15. Period is very heavy with tons of blood clots some have been as big as a strawberry ( I?ve never had blood clots in my period ever ) cycle is completely off days are all messed up I?m ovulating the day my period stops.
Fine macular rash on head (scalp), trunk, and extremities. No fever or other symptoms. Rash is slightly itchy. Started 10 days after MMR vaccine.
Localized redness and itching at injection site.  No other signs or symptoms reported by patient or observed by provider.
The morning after the shot patient noticed redness and a little soreness, she looked this morning and arm is really inflamed red and radiating down arm. There is a swollen area antecubital and it is very sore to the touch.
EXTREAM FUSSINESS GREATER THAN 6 HOURS TEMP TO 102 18 HOURS LATER.  12/03/2007 MR received for DOS 10/16-18/2007 with DX: fussiness. Mother reported inconsolable crying with vomiting after receiving vax.  Child was found to be tachycardic (HR 166) and was admitted for post-immunization reaction, increased fussiness, emesis. Child developed a fever of 102 after admission and was txd with abx.
Johnson and Johnson vaccine given at 1:49 pm.  Patient stated they felt really hot, dizzy and was having spotty vision. At 1:57 50mg of generic benadryl was given with water since patient was able to swallow.  Pharmacist had patient lie on floor with feet up on chair and cold pack on forehead.  After 5 to 10 minutes patient was feeling better. Vision returned to normal. Blood pressure taken was 102/68 pulse of 67, which was near normal per patient. Patient continued to lie on their back until she felt well enough to sit up.  Her primary care doc was notified and the nurse there recommended pt go to the emergency room.  The patient was going to be with boyfriend rest of the day and evening. They purchased benadryl  to take with them.
SWELLING AT ELBOW, MILD ELBOW EFFUSION, WARMTH, ERYTHEMA AND TENDERNESS TO ELBOW AND FOREARM. NO FEVER OR OTHER SYMPTOMS. PATIENT SEEN AND TREATED AT URGENT CARE CENTER.
This spontaneous report was received from a physician referring to herself, a female patient of unknown age. The patient's medical history and concomitant medications were not reported. On an unknown date the patient was vaccinated subdermally with PNEUMOVAX 23 (dosage, dose number and lot number were unknown. Additional information has been requested.
Extreme soreness and weakness in left arm, sore throat, constant headache, body aches, all symptoms started the morning after vaccination and have persisted so far x 2 days.
Pt received first Moderna vaccine 1/8/21 only had reaction of a sore arm, then received second vaccine 2/5/21, had usual side effects of effects of fatigue, arm soreness, muscle aches. on 2/8/2021 patient awoke at 2am and nose was swollen due to multiple herpes simplex type 1 sores in nostrils, lips and mouth swollen. no sores in mouth. getting waves of nausea. pt is fatigued.
Severe vomiting.  Fever. Exhaustion.  Muscle aches all body. 5 days later, severe vertigo incident with vomiting. Vertigo continued one week daily basis and now continues Intermittent.  Most recent Wednesday may 12t severe and moderate Friday night May 14th
Pain and erythema at site of immunization (R) Deltoid worsening 10-30-10 and 10-31-10. (R) deltoid, pruritic. Advised ice to site, TYLENOL and BENADRYL 25 mg po q 6 hours prn on 11-1-10. 11-3-10 (R) deltoid decreased edema, (+) pruritus, erythema and tenderness resolving. Applied BENADRYL creme topically with relief.
Information has been received from a registered pharmacist concerning her 22 year old daughter with a lobster allergy and a history of a tonsillectomy 5 years ago and chickenpox in childhood who on 20-MAY-2008 was vaccinated with the first dose of GARDASIL vaccine (yeast) 0.5ml IM. Concomitant therapy included YAZ. Subsequently, not long after vaccination, the patient experienced "a little" redness at the injection site which resolved on its own. One week after the vaccination (on approximately 27-MAY-2008) the patient developed a "rash". The patient also developed poison ivy at the time. The "rash" had persisted since that time. The rash looked like tiny hives that itch, no drainage noted. The patient had seen her primary physician and a dermatologist. The patient was prescribed 2 courses of MEDROL dose pack and multiple creams that have been resolved the rash. The rash had completely resolved and then come back again. The location of the rash changed each time it returned. It has been located on her arms, legs, knees, and thighs at different times. The dermatologist stated that it may be caused from a virus or nerves. Additional information has been requested.
Large red area (rash 4 x 6 inches ) on injection arm.  Started  7 days after injection, lasted for 4 days.  Slight numbness  lower left arm that started day 8, lasted for  2 days.
Patient had significant swelling in both arms, although greater in the right arm. She went to the hospital, was examined and was given BENADRYL and a course of oral antibiotics.
Case number PHEH2011US02192 is an initial spontaneous report received from a health care professional on 19 Aug 2011. This report refers to a female child. She was given only the MenA lyophilized powder component of MENVEO vaccine (batch number: 10047 and expiry date: Dec 2012) without being reconstituted with the MenCWY lyophilized liquid component, intramuscularly on 11 Aug 2011. No other adverse reaction was reported.
This spontaneous report received from a patient concerned a 47 year old male. The patient's height, and weight were not reported. The patient's concurrent conditions included non smoker, and non-alcohol user, and other pre-existing medical conditions included the patient had no known allergies and no history of drug abuse or illicit drug use. The patient received COVID-19 vaccine ad26.cov2.s (suspension for injection, route of admin not reported, batch number: 1808986, expiry: UNKNOWN) dose was not reported, administered on 02-JUNE-2021 for prophylactic vaccination. No concomitant medications were reported. On 02-JUNE-2021, the subject experienced pain in eyes. On 02-JUNE-2021, the subject experienced flu like symptoms. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The patient had not recovered from pain in eyes, and flu like symptoms. This report was non-serious.
This spontaneous report as received from a registered nurse refers to the unspecified number of patients of unknown age and gender. It was reported that 42 doses of PNEUMOVAX 23 (doses and units were not reported) were improperly stored and administered to patient since 11-SEP-2014. No adverse events were reported. This is one of several reports from the same reporter. Additional information has been requested.
This spontaneous report as received from a registered nurse refers to a 29 year old patient. On 08-AUG-2014 the patient was inadvertently vaccinated with RECOMBIVAX HB 40 (unspecified in series), lot # H010965, Expiration Date 01-JUN-2014, 1 ml, once, intramuscularly. No adverse effects reported. Additional information has been requested.
LUMP IN THROAT, RED, SPLOTCHY ON NECK, TINGLING OF LIPS AND MOUTH, TROUBLE BREATHING ABOUT 2-3 MINUTES AFTER VACCINE INJECTED.   BENADRYL 50MG IM GIVEN.
Was due for the 2nd when Covid hit hard; This case was reported by a consumer via (interactive digital media and described the occurrence of social problem in a male patient who received Herpes zoster (Shingles vaccine) for prophylaxis.   The patient's past medical history included neurological disorder nos and pruritus. Previously administered products included Gabapentine (had gabapentin for nerves ot itch) and Shingles vaccine (1st dose received on an unknown date, refer case US2021AMR176118).   On an unknown date, the patient received the 2nd dose of Shingles vaccine. On an unknown date, unknown after receiving Shingles vaccine, the patient experienced social problem. On an unknown date, the outcome of the social problem was unknown.  Additional details were provided as follows: The reporter was the patient's wife. The age at vaccination was not applicable for this report. The reporter stated that, the patient had been on Gabapentin for the nerves/ itch. The patient was due for the 2nd dose when Covid hit hard. The follow-up would not possible as no contact details were available.; Sender's Comments:  US-GLAXOSMITHKLINE-US2021AMR176118:Same reporter.
Very pleasant 43-year-old female who is status post renal transplant presenting the emergency department for evaluation.  The patient notes leg weakness, nausea, vomiting, diarrhea, shortness of breath.  These min going on 3-4 days.  The patient was diagnosed as COVID 19 positive on 08/15/2021.  These have been worsening since that time.  Here in the emergency department the patient's vital signs were stable.  Renal function at baseline.  However, she had significant exertional hypoxemia.  She is admitted for further management.
Patient was given DTAP, MMR, Hep A. Patient was given MCV4 and was suppose to receive varicella. I had wrote the order incorrect to MA. She did not check the chart and gave what I had ordered. We will contact parents.
This is a spontaneous report from a Pfizer-sponsored program. A contactable consumer reported for her son. A 19-year-old male patient of an unspecified ethnicity received the first dose of TRUMENBA, via an unspecified route of administration on 11Aug2016 at single dose for immunization. The patient medical history and concomitant medications were not reported. The patient experienced awful fever, chills, fatigue, shaky and sick as a dog on an unspecified date with outcome of unknown. Now it's been almost a year and the patient did not receive the second dose yet. No follow-up attempts are possible. No further information is expected. Follow-up (21Jul2017): additional information received from the contactable consumer includes age of the patient and date of vaccination. Sender's Comments: Linked Report(s): 2016395485 Legacy paper report number.
Diagnosed with Bell's Palsy on 4/27/21 with symptoms of weakening of muscles on left side of face and numbness of tongue.  Recovered from Bell's Palsy within 3 weeks.  High fever on 6/2/21 with muscle weakness, skin sensitivity to touch, tremors in hands and legs and light headedness.  Seen at emergency on 6/2 and received negative COVID-19 test.   Recovered from all symptoms except light headeness and muscle weakness in legs.  Referred to neurologist.  Received EMG test on 7/21 and diagnosed with Guillain-Barre.  Muscle weakness in legs persists to present day as does light headedness.  Mobility is significant reduced.  Can still walk but it is difficult to climb stairs and walking speed is about 30-50% normal speed.
Low grade temp; headache; achy; diarrhea; tiredness; This is a spontaneous report from a contactable nurse (patient). A 41-year-old female patient received the first dose of bnt162b2 (Pfizer Biontech COVID 19 vaccine), Lot number: EJ1685, via an unspecified route of administration on the left arm on 19Dec2020 11:30 at a single dose for COVID-19 immunization. The patient's medical history and concomitant medications were not reported. The patient was not pregnant. The patient has no allergies to medications, food, or other products. On 20Dec2020 11:00, the patient experienced low grade temp, headache, achy, diarrhea and tiredness. The patient did not receive any treatment for the events and were reported as non-serious. The vaccine was administered in a hospital. The patient has not received any other vaccines within 4 weeks prior to the COVID vaccine. Prior to vaccination the patient was not diagnosed with COVID-19. Since the vaccination, the patient has not been tested for COVID-19. The outcome of events  low grade temp, headache, achy, diarrhea and tiredness was recovered on an unspecified date in Dec2020.
Patient fainted after immunization given and was incontinent of urine. Vitals were stable & patient recovered quickly.
TEETH  CHATTERING; NAUSEA; HEADACHE; SHAKY FEVER/FEVER GREATER THEN 104F; CLAMMY; FAST HEART RATE; CHEST TIGHTNESS; This spontaneous report received from a patient concerned a 45 year old female. The patient's height, and weight were not reported. The patient's concurrent conditions included allergy to hazelnut, allergy to latex, alcoholic (2 -3 glasses on weekend), and non smoker, and other pre-existing medical conditions included patient had no previous medical history and had no drug abuse/illicit. The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, intramuscular, batch number: 202A21A, and expiry: UNKNOWN) dose was not reported, administered on 08-APR-2021 11:22 for prophylactic vaccination. Concomitant medications included ibuprofen for fever, and paracetamol for fever. On 08-APR-2021, the subject experienced chest tightness. Laboratory data included: Body temperature (NR: not provided) Greater then 104 F. On 08-APR-2021 17:30, the subject experienced clammy. On 08-APR-2021 17:30, the subject experienced fast heart rate. On 08-APR-2021 17:30, the subject experienced teeth chattering. On 08-APR-2021 17:30, the subject experienced nausea. On 08-APR-2021 17:30, the subject experienced headache. On 08-APR-2021 17:30, the subject experienced shaky fever/fever greater then 104F. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The patient recovered from clammy, and fast heart rate, and chest tightness on 08-APR-2021, was recovering from shaky fever/fever greater then 104f, and teeth chattering, and had not recovered from nausea, and headache. This report was non-serious.
Information has been received from a physician concerning a female patient who several years ago, on unspecified dates was vaccinated with the three doses of RECOMBIVAX HB (manufacturer unknown). On an unspecified date, the patient had a low or negative Hepatitis B titer. Subsequently, the patient was vaccinated with a fourth dose of RECOMBIVAX HB (manufacturer unknown). Then the patient's Hepatitis B titer levels were very high when they were retested. Additional information has been requested.
SOUR TASTE BUDS; BODY ACHES; DIARRHEA; CHILLS; HEADACHES; This spontaneous report received from a patient concerned a 29 year old female. The patient's height, and weight were not reported. The patient's pre-existing medical conditions included the patient was not pregnant at the time of reporting. The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, route of admin not reported, batch number: Unknown) dose was not reported, administered on 10-APR-2021 for prophylactic vaccination. The batch number was not reported and has been requested. No concomitant medications were reported. On 11-APR-2021 03:00, the subject experienced sour taste buds. On 11-APR-2021 03:00, the subject experienced body aches. On 11-APR-2021 03:00, the subject experienced diarrhea. On 11-APR-2021 03:00, the subject experienced chills. On 11-APR-2021 03:00, the subject experienced headaches. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The patient recovered from body aches, diarrhea, chills, and headaches on 12-APR-2021, and had not recovered from sour taste buds. This report was non-serious.